Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ryan Nelson

Managing Editor, Rose Sheet

Washington, D.C.
I joined FDC Reports (The Gray Sheet) in October 2004, so have been with the business that Informa inquired from Elsevier for almost 12 years. In my current role, I either write or edit all Rose Sheet content. My expertise is in the areas of cosmetics industry regulation, legal issues in the sector, the competitive landscape, marketplace dynamics, etc. 
Set Alert for Articles By Ryan Nelson

Latest From Ryan Nelson

FDA To Try Its Hand At Sunscreen Absorption Study, A MUsT For TEA Sponsors

Agency may be teaming with an outside party to conduct a maximum usage trial on sunscreen formulations. FDA guidance advises MUsTs to assess systemic exposure to sunscreen drug ingredients, but ingredient sponsors have been loath to invest in such tests due to questions about cost and viability.

FDA Clinical Trials

FDA ‘Actively Investigating’ Asbestos In Cosmetics; Claire’s Rebuts New Allegations

Health Canada’s investigation cleared Claire’s makeup previously linked to asbestos by Scientific Analytical Institute, the same lab whose asbestos findings Tween Brands disputed last year before launching a recall based on its own testing. Cosmetics manufacturers using talc should try to keep up.

Cosmetic Ingredients FDA

CIR’s Ginkgo Biloba Review Illustrates Growing Botanical Challenges

The Cosmetic Ingredient Review Expert Panel issued a tentative insufficient data report for Ginkgo biloba-derived ingredients at its March 5-6 meeting. The panel’s struggle to map available ingredient information and toxicity data to specific uses in the cosmetics sector signals botanical review challenges that are likely to become only more frequent.

Cosmetic Ingredients Safety

CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now

Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions. 
Cosmetic Ingredients Safety

ECHA Requests Stakeholder Input On Microplastic Use; Possible Restrictions To Follow

The cosmetics industry likely will want to steer ECHA away from leave-on cosmetics and non-cleansing/exfoliating rinse-off products containing microplastic particles. NGOs and lawmakers in some European member states have called for microplastic bans that include those product categories, which would exceed prohibitions in the US and phase-outs voluntarily undertaken by industry.
Regulation Cosmetic Ingredients

Trans-Pacific Partnership Lives: US Out, But Cosmetics Annex Still In

Eleven countries have salvaged and rebranded the international trade deal abandoned by President Donald Trump in early 2017, with a signing ceremony slated for March 8 in Chile. The CPTPP retains much of the original TPP, including a cosmetics annex to promote harmonization around regulatory best practices.
Trade Regulation
See All